Pathogenesis of Anemia during Human Immunodeficiency Virus Infection

Spivak JL , Bender BS , Quinn TC. Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med 1984;77:224–228.

Polk BF , Fox R , Brookmeyer R , . Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987;316:61–66.

Moore RD. Human immunodeficiency virus infection, anemia, and survival. Clin Infect Dis 1999;29:44–49.

Aboulafia DM , Mitsuyasu RT. Hematologic abnormalities in AIDS. Hematol Oncol Clin North Am 1991;5:195–214.

Ellaurie M , Burns ER , Rubinstein A. Hematologic manifestations in pediatric HIV infection: Severe anemia as a prognostic factor. Am J Pediatr Hematol Oncol 1990;12:449–453.

Barroso J. A review of fatigue in people with HIV infection. J Assoc Nurses AIDS Care 1999;10:42–49.

Semba RD , Tang AM. Micronutrients and the pathogenesis of human immunodeficiency virus infection. Br J Nutr 1999;81:181–189.

Kreuzer KA , Rockstroh JK. Pathogenesis and pathophysiology of anemia in HIV infection. Ann Hematol 1997;75:179–187.

Spivak JL , Barnes DC , Fuchs E , Quinn TC. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA 1989;261:3104–3107.

Fuchs D , Zangerle R , Artner-Dworzak E , . Association between immune activation, changes of iron metabolism, and anaemia in patients with HIV infection. Eur J Hematol 1993;50:90–94.

Kravcik S , Toye BW , Fyke K , . Impact of Mycobacterium avium complex prophylaxis on the incidence of mycobacterial infections and transfusion-requiring anemia in an HIV-positive population. J Acquir Immun Defic Syndr Hum Retrovirol 1996;13:27–32.

Abkowitz JL , Brown KE , Wood RW , Kovach NL , Green SW , Young NS. Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis 1997;176:269–273.

Folks TM , Kessler SW , Orenstein JM , Justement JS , Jaffe ES , Fauci AS. Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science 1988;242:919–922.

Moses A , Nelson J , Bagby GC Jr. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 1998;91:1479–1495.

Pluda JM , Mitsuya H , Yarchoan R. Hematologic effects of AIDS therapies. Hemat Oncol Clin North Am 1991;5:229–248.

Quinn TC. Global burden of the HIV pandemic. Lancet 1996;348:99–106.

Yip R , Dallman PR. Iron.In: Ziegler EE , Filer LJ Jr , eds.Present knowledge in nutrition, 7th ed. Washington, DC: ILSI Press, International Life Sciences Institute; 1996:277–292.

Turner BJ , Hauck WW , Fanning TR , Markson LE. Cigarette smoking and maternal-child HIV transmission. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:327–337.

Burns DN , FitzGerald G , Semba RD , . Vitamin A deficiency and other nutritional indices during pregnancy in human immunodeficiency virus infection: prevalence, clinical correlates, and outcome. Clin Infect Dis 1999;29:328–334.

St Louis ME , Kamenga M , Brown C , . Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA 1993;269:2853–2859.

Bobat R , Coovadia H , Coutsoudis A , Moodley D. Determinants of mother-to-child transmission of human immunodeficiency virus type 1 infection in a cohort from Durban, South Africa. Pediatr Infect Dis J 1996;15:604–610.

Ladner J , Leroy V , Hoffman P , . Chorioamnionitis and pregnancy outcome in HIV-infected African women. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:293–298.

Coutsoudis A , Pillay K , Spooner E , Kuhn L , Coovadia HM. South African Vitamin A Study Group. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. AIDS 1999;13:1517–1524.

John GC , Nduati RW , Mbori-Ngacha D , . Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: Association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 1997;175:57–62.

Meda N , Mandelbrot L , Cartoux M , Dao B , Ouangre A , Dabis F. Anaemia during pregnancy in Burkina Faso, west Africa, 1995 96. DITRAME Study Group Bull World Health Organ 1999;77:916–922.

Ramon R , Sawadogo D , Koko FS , . Haematological characteristics and HIV status of pregnant women in Abidjan, Côte d'Ivoire, 1995 96. Trans R Soc Trop Med Hyg 1999;93:419–422.

Semba RD , Kumwenda N , Hoover DR , . Assessment of iron status using plasma transferrin receptor in pregnant women with and without human immunodeficiency virus infection in Malawi. Eur J Clin Nutr 2000;54:872–877.

Italian Register for HIV Infection in Children. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 1994;343:191–195.

Adewuyi J , Chitsike I. Haematologic features of the human immunodeficiency virus (HIV) infection in black children in Harare. Cent Afr J Med 1994;40:333–336.

Greenberg BL , Semba RD , Schoenbaum EE , Klein RS. Vitamin A deficiency among former and current injecting drug users in Bronx, New York. Nutr Res 1997;17:785–796.

Saah AJ , Hoover DR , He Y , Kingsley LA , Phair JP. Multicenter AIDS Cohort Study. Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS). J Acquir Immune Defic Syndr 1994;7:287–295.

Swanson CE , Tindall B , Cooper DA. Australian Zidovudine Study Group.Efficacy of zidovudine treatment in homosexual men with AIDS-related complex: Factors influencing development of AIDS, survival, and drug intolerance. AIDS 1994;8:625- 634.

Van der Werf MJ , van Benthem BHB , van Ameijden AJC Prevalence, incidence and risk factors of anaemia in HIV-positive and HIV-negative drug users. Addiction 2000;95:383–392.

Creagh-Kirk T , Doi P , Andrews E , . Survival experience among patients with AIDS receiving zidovudine: Follow-up of patients in a compassionate plea program. JAMA 1988;260:3009–3015.

Steinberg JP , Spear JB , Murphy RL , . Predictors of outcome in AIDS patients receiving zidovudine. J Acquir Immune Defic Syndr 1989;2:229–234.

Swanson CE , Cooper DA. Australian Zidovudine Study Group.Factors influencing outcome of treatment with zidovudine of patients with AIDS in Australia. AIDS 1990;4:749 -757.

Moore RD , Keruly J , Richman DD , Creagh-Kirk T , Chaisson RE. Zidovudine Epidemiology Study Group.Natural history of advanced HIV disease in patients treated with zidovudine. AIDS 1992;6:671- 677.

Semba RD , Caiaffa WT , Graham NMH , Cohn S , Vlahov D. Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. J Infect Dis 1995;171:1196–1202.

Turner BJ , Markson L , Taroni F. Estimation of survival after AIDS diagnosis: CD4+ lymphocyte count versus clinical severity. J Clin Epidemiol 1996;49:59–65.

Spino C , Kahn JO , Dolin R , Phair JP. Predictors of survival in HIV-infected persons with 50 or fewer CD4 cells/mm3. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:346–355.

Sullivan PS , Hanson DL , Chu SY , Jones JL , Ward JW , and the Adult/Adolescent Spectrum of Disease Group. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the Multistate Adult and Adolescent Spectrum of HIV Disease Surveillance Project. Blood 1998;91:301–308.

UNICEF/UNU/WHO/MI. Preventing iron deficiency in women and children. Technical consensus on key issues. Boston International Nutrition Foundation; 1999.

Allen LH. Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin Nutr 2000;71(suppl):1280S-1284S.

Allen LH. Pregnancy and iron deficiency : Unresolved issues. Nutr Rev 1997;55:91–101.

Murphy JF , O'Riordan J , Newcombe RG , . Relation of haemoglobin levels in the first and second trimesters to outcome of pregnancy. Lancet 1986;1:992–994.

Mueller BU , Tannenbaum S , Pizzo PA. Bone marrow aspirates and biopsies in children with human immunodeficiency virus infection. J Pediatr Hemat Oncol 1996;18:266–271.

Van den Broek NR , Letsky EA , White SA , Shenkin A . Iron status in pregnant women: Which measurements are valid? Br J Haematol 1998;103:817–824.

Massawe SN , Urassa ENJ , Mmari M , Ronquist G , Lindmark G , Nystrom L. The complexity of pregnancy anemia in Dar-es-Salaam. Gynecol Obstet Invest 1999;47:76–82.

Beach RS , Mantero-Atienza E , Shor-Posner G , . Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS 1992;6:701–708.

Guarino A , Albano F , Tarallo L , . Intestinal malabsorption of HIV-infected children: Relationship to diarrhoea, failure to thrive, enteric micro-organisms and immune impairment. AIDS 1993;7:1435–1440.

De Vizia B , Poggi V , Connena R , Fiorillo A , Scippa L. Iron absorption and iron deficiency in infants and children with gastrointestinal disease. J Pediatr Gastroenterol Nutr 1992;14:21–26.

Castaldo A , Tarallo L , Palomba E , . Iron deficiency and intestinal malabsorption in HIV disease. J Pediatr Gastroenterol Nutr 1996;22:359–363.

Belitsos PC , Greenson JK , Yardley JH , Sisler JR , Bartlett JG. Association of gastric hypoacidity with opportunistic enteric infections in patients with AIDS. J Infect Dis 1992;166:277–284.

Tarimo DS , Killewo JZ , Minjas JN , Msamanga GI. Prevalence of intestinal parasites in adult patients with enteropathic AIDS in north-eastern Tanzania. East Afr Med J 1996;73:397–399.

Khumalo-Ngwenya B , Luo NP , Chintus C ,etal. Gut parasites inHIV-seropositive Zambian adults with diarrhoea.East Afr Med J1994;71:379–383.

Gupta S , Imam A , Licorish K. Serum ferritin in acquired immune deficiency syndrome. J Clin Lab Immunol 1986;20:11–13.

Boelaert JR , Weinberg GA , Weinberg ED. Altered iron metabolism in HIV infection: Mechanisms, possible consequences, and proposals for management. Infect Agents Dis 1996;5:36–46.

Savarino A , Pescarmona GP , Boelaert JR. Iron metabolism and HIV infection: Reciprocal interactions with potentially harmful consequences? Cell Biochem Funct 1999;17:279–287.

Costagliola DG , Montalembert M , Lefrère JJ , . Dose of desferrioxamine and evolution of HIV-1 infection in thalassaemic patients. Br J Haematol 1994;87:849–852.

Sahli Y , Castagliola D , Rebulla P , . Serum ferritin, desferrioxamine, and evolution of HIV-1 infection in thalassemic patients. J Acquir Immune Defic Hum Retrovirol 1998;18:473–478.

Salmon-Céron D , Fontbonne A , Saba J , . Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. J Infect Dis 1995;172:656–664.

Vildé JL , Salmon-Céron D. Reply [letter]. J Infect Dis 1996;1731045–1046.

Jacobus DP. Randomization to iron supplementation of patients with advanced human immunodeficiency virus disease: An inadvertent but controlled study with results important for patient care. J Infect Dis 1996;173:1044–1045.

Georgiou NA , van der Bruggen T , Oudshoorn M , Nottet HSLM , Marx JJM , van Asbeck BS. Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxime, deferiprone, and bleomycin. J Infect Dis 2000;181:484–490.

Delanghe JR , Langlois MR , Boelaert JR , . Haptoglobin polymorphism, iron metabolism, and mortality in HIV infection. AIDS 1998;12:1027–1032.

De Monyé C , Karcher DS , Boelaert JR , Gordeuk VR. Bone marrow macrophage iron grade and survival of HIV-seropositive patients. AIDS 1999;13:375–380.

Bogden JD , Baker H , Frank O , . Micronutrient status and human immunodeficiency virus (HIV) infection. Ann N Y Acad Sci 1990;587:189–195.

Skurnick JH , Bogden JD , Baker H , . Micronutrient profiles in HIV-1-infected heterosexual adults. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:75–83.

Coodley G , Girard DE. Vitamins and minerals in HIV infection. J Gen Intern Med 1991;6:472–479.

Tang AM , Graham NMH , Chandra RK , Saah AJ. Relation between serum vitamin B6, B12, and folate levels and human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr 1997;127:345–351.

Boudes P , Zittoun J , Sobel A. Folate vitamin B12, and HIV infection. Lancet 1990;335:1401–1402.

Beach RS , Mantero-Atienza E , Eisdorfer C , Fordyce-Baum MK. Altered folate metabolism in early HIV infection. JAMA 1988;259:518.

Tilkian SM , Lefevre G , Coyle C. Altered folate metabolism in early HIV infection. JAMA 1988;259:3128–3129.

Revell P , O'Doherty MJ , Tang A , Savidge GF. Folic acid absorption in patients infected with the human immunodeficiency virus. J Intern Med 1991;230:227–231.

Fishman SM , Christian P , West KP Jr. The role of vitamins in the prevention and control of anemia. Public Health Nutr 2000;3:125–150.

Burkes RL , Cohen H , Krailo M , Sinow RM , Carmel R. Low serum cobalamin levels occur frequently in the acquired immune deficiency syndrome and related disorders. Eur J Haematol 1987;38:141–147.

Harriman GR , Smith PD , Horne MK , Fox CH , Koenig S , Lack EE , Lane HC , Fauci AS. Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. Arch Intern Med 1989;149:2039–2041.

Paltiel O , Falutz J , Veilleux M , Rosenblatt DS , Gordon K. Clinical correlates of subnormal vitamin B12 levels in patients infected with the human immunodeficiency virus. Am J Hematol 1995;49:318–322.

Rule SAJ , Hooker M , Costello C , Luck W , Hoffbrand AV. Serum vitamin B12 and transcobalamin levels in early HIV disease. Am J Hematol 1994;47:167–171.

Kieburtz KD , Giang DW , Schiffer RB , Yakil N. Abnormal vitamin B12 metabolism in human immunodeficiency virus infection: Association with neurological dysfunction. Arch Neurol 1991;48:312–314.

Veilleux M , Paltiel O , Falutz J. Sensorimotor neuropathy and abnormal vitamin B12 metabolism in early HIV infection. Can J Neurol Sci 1995;22:43–46.

Mantero-Atienza E , Baum MK , Morgan R , Wilkie F , Shor-Posner G , Fletcher MA , Eisdorfer C , Beach RS. Vitamin B12 deficiency in early human immunodeficiency virus-1 infection. Arch Intern Med 1991;151:1019–1020.

Herbert V , Fong W , Gulle V , Stopler T. Low holotranscobalamin II is the earliest serum marker for subnormal vitamin B12 (cobalamin) absorption in patients with AIDS. Am J Hematol 1990;34:132–139.

Remacha AF , Montagud M , Cadafalch J , Riera A , Martino R , Gimferrer E. Vitamin B12 transport proteins in patients with HIV-1 infection and AIDS. Haematologica 1993;78:84–88.

Modigliani R , Bories C , Le Charpentier Y , . Diarrhoea and malabsorption in acquired immune deficiency syndrome: A study of four cases with special emphasis on opportunistic protozoan infestations. Gut 1985;26:179–187.

Kapembwa MS , Bridges C , Joseph AEA , Fleming SC , Batman P , Griffin GE. Ileal and jejunal absorptive function in patients with AIDS and enterococcidial infection. J Infect 1990;21:43–45.

Ehrenpreis ED , Carlson SJ , Boorstein HL , Craig RM. Malabsorption and deficiency and vitamin B12 in HIV-infected patients with chronic diarrhea. Dig Dis Sci 1994;39:2159–2162.

Goodgame RW , Kimball K , Ou CN , . Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology 1995;108:1075–1082.

Herzlich BC , Schiano TD , Moussa Z , . Decreased intrinsic factor secretion in AIDS: Relation to parietal cell acid secretory capacity and vitamin B12 malabsorption. Am J Gastroenterol 1992;87:1781–1787.

Tang AM , Graham NMH , Chandra RK , Saah AJ. Relation between serum vitamin B6, B12, and folate levels and human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr 1997;127:345–351.

Semba RD , Muhilal , West KP Jr , . Effect of vitamin A supplementation on hematological indicators of iron metabolism and nutritional status in children. Nutr Res 1992;12:469–478.

Bloem MW. Interdependence of vitamin A and iron: An important association for programmes of anaemia control. Proc Nutr Soc 1995;54:501–508.

Okano M , Masuda S , Narita H , . Retinoic acid up-regulates erythropoietin production in hepatoma cells and in vitamin A-depleted rats. FEBS Lett 1994;349:229–233.

Jelkmann W , Pagel H , Hellwig T , Fandrey J. Effects of antioxidant vitamins on renal and hepatic erythropoietin production. Kidney Int 1997;51:497–501.

Semba RD. Vitamin A and human immunodeficiency virus infection. Proc Nutr Soc 1997;56:459–469.

Suharno D , West CE , Muhilal , Karyadi D , Hautvast JG. Supplementation with vitamin A and iron for nutritional anaemia in pregnant women in West Java, Indonesia. Lancet 1993;342:1325–1328.

Means RT Jr , Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992;80:1639–1647.

Cash JM , Sears DA. The anemia of chronic disease: Spectrum of associated disease in a series of unselected hospitalized patients. Am J Med 1989;87:638–644.

Spivak JL. The blood in systemic disorders. Lancet 2000;355:1707–1712.

Cartwright GE. The anemia of chronic disorders. Semin Hematol 1966;3:351–375.

Erslev AJ , Wilson J , Caro J. Erythropoietin titers in anemic, nonuremic patients. J Lab Clin Med 1987;109:429–433.

Erslev AJ. Erythropoietin. N Engl J Med 1991;324:1339–1344.

Spivak JL , Barnes DC , Fuchs E , Quinn TC. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA 1989;261:3104–3107.

Rarick MU , Loureiro C , Groshen S , . Serum erythropoietin titers in patients with human immunodeficiency virus (HIV) infection and anemia. J Acquir Immune Defic Syndr 1991;4:593–597.

Camacho J , Poveda F , Zamorano AF , Valencia ME , Vásquez JJ , Arnalich F. Serum erythropoietin levels in anaemic patients with advanced human immunodeficiency virus infection. Br J Haematol 1992;82:608–614.

Kreuzer KA , Rockstroh JK , Jelkmann W , Theisen A , Spengler U , Sauerbruch T. Inadequate erythropoietin response to anaemia in HIV patients: Relationship to serum levels of tumour necrosis factor-alpha, interleukin-6, and their soluble receptors. Br J Haematol 1997;96:235–239.

Murphy M , Perussia B , Trinchieri G. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells. Exp Hematol 1988;16:131–138.

Fuchs D , Reibnegger G , Werner ER , Vinazzer H , Wachter H. Low haemoglobin in haemophilia children is associated with chronic immune activation. Acta Haematol 1991;85:62–65.

Sipsas NV , Kokori SI , Ioannidis JPA , Kyriaki D , Tzioufas AG , Kordossis T. Circulating autoantibodies to erythropoietin are associated with human immunodeficiency virus type 1-related anemia. J Infect Dis 1999;180:2055–2157.

Barosi G. Inadequate erythropoietin response to anemia: Definition and clinical relevance. Ann Hematol 1994;68:215–223.

Wang Z , Goldberg MA , Scadden DT. HIV-1 suppresses erythropoietin production in vitro. Exp Hematol 1993;21:683–688.

Fischl M , Galpin JE , Levine JD , . Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990;322:1488–1493.

Henry DH , Beall GN , Benson CA , . Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy: Overview of four clinical trials. Ann Intern Med 1992;117:739–748.

Phair JP , Abels RI , McNeill MV , Sullivan DJ. Recombinant human erythropoietin treatment: Investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome: Overall results. Arch Intern Med 1993;153:2669–2675.

Revicki DA , Brown RE , Henry DH , McNeill MC , Rios A , Watson T. Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia. J Acquir Immune Defic Syndr 1994;7:474–484.

Goodnough LT , Anderson KC , Kurtz S , . Indications and guidelines for the use of hematopoietic growth factors. Transfusion 1993;33:944–959.

Zuccotti GV , Flumine P , Locatelli V , Banderali G , Riva E. Growth factors and HIV-infection in children. J Int Med Res 1993;21:342–345.

Havlik JA Jr , Horsburgh CR Jr , Metchock B , Williams PP , Fann SA , Thompson SE. Disseminated Mycobacterium avium complex infection: Clinical identification and epidemiological trends. J Infect Dis 1992;165:577–580.

Shafran SD. Prevention and treatment of disseminated Mycobacterium avium complex infection in human immunodeficiency virus-infected individuals. Int J Infect Dis 1998;3:39–47.

Nightingale SD , Byrd LT , Southern PM , Jockusch JD , Cal SX , Wynne BA. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 1992;165:1082–1085.

Horsburgh CR Jr. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991;324:1332–1338.

Sathe SS , Gascone P , Lo W , Pinto R , Reichman LB. Severe anemia is an important negative predictor for survival with disseminated Mycobacterium avium-intracellulare in acquired immunodeficiency syndrome. Am Rev Respir Dis 1990;142:1306–1312.

Wallace JM , Hannah JB. Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome: A clinicopathological study. Chest 1988;93:926–932.

Nightingale SD , Cameron DW , Gordin FM , . Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993;329:828–833.

Gascón P , Sathe SS , Rameshwar P. Impaired erythropoiesis in the acquired immunodeficiency syndrome with disseminated Mycobacterium avium complex. Am J Med 1993;94:41–48.

Ellaurie M , Rubinstein A. Elevated tumor necrosis factor-alpha in association with severe anemia in human immunodeficiency virus infection and Mycobacterium avium intracellulare infection. Pediatr Hematol Oncol 1995;12:221–230.

Gardener TD , Flanagan P , Dryden MS , Costello C , Shanson DC , Gazzard BG. Disseminated Mycobacterium avium-intracellulare infection and red cell hypoplasia in patients with the acquired immune deficiency syndrome. J Infect 1988;16:135–140.

Mir N , Costello C , Luckit J , Lindley R. HIV-disease and bone marrow changes: A study of 60 cases. Eur J Haematol 1989;42:339–343.

Anderson MJ. Parvoviruses as agents of human disease. Prog Med Virol 1987;34:55–69.

Brown T , Anand A , Ritchie LD , Clewley JP , Reid TMS. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984;2:1033–1034.

Pont J , Puchhammer-Stöckl E , Chott A , . Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection. Br J Haematol 1992;80:160–165.

Frickhofen N , Abkowitz JL , Safford M , . Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): A treatable cause of anemia in AIDS. Ann Intern Med 1990;113:926–933.

Gyllensten K , Sönnerborg A , Jorup-Rönström C , Halvarsson M , Yun Z. Parvovirus B19 infection in HIV-1 infected patients with anemia. Infection 1994;22:356–358.

Leads from the MMWR.Risks associated with human parvovirus B19 infection. JAMA 1989;2611406–1408, 1555–1563.

Cohen BJ , Mortimer PP , Pereira MS. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hygiene 1983;91:113–130.

Liu W , Ittmann M , Liu J , . Human parvovirus B19 in bone marrows from adults with acquired immunodeficiency syndrome: A comparative study using in situ hybridization and immunohistochemistry. Hum Pathol 1997;28:760–766.

Chernak E , Dubin G , Henry D , . Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. Clin Infect Dis 1995;20:170–173.

Van Elsacker-Neile AMW , Kroon FP , van der Ende ME , Salimans MMM , Spaan WJM , Kroes ACM . Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus. Clin Infect Dis 1996;23:1255–1260.

Raguin G , Leruez-Ville M , Gregoire V , Deplanche M , Leport C , Morinet F , Vilde JL. Low prevalence of active parvovirus B19 infection in HIV-infected patients. Eur J Clin Microbiol Infect Dis 1997;16:760–762.

Naides SJ , Howard EJ , Swack NS , True CA , Stapleton JT. Parvovirus B19 infection in human immunodeficiency virus type 1-infected persons failing or intolerant to zidovudine therapy. J Infect Dis 1993;168:101–105.

Fuller A , Moaven L , Spelman D , Spicer WJ , Wraight H , Curtis D , Leydon J , Doultree J , Locarnini S. Parvovirus B19 in HIV infection: A treatable cause of anemia. Pathology 1996;28:277–280.

Ramratnam B , Gollerkeri A , Schiffman FJ , Rintels P , Flanigan TP. Management of persistent B19 parvovirus infection in AIDS. Br J Haematol 1995;91:90–92.

Martins A , Costa A , Oliveira MJ , Rodrigues M , Ribeiro AP , Silvestre F , Reis A. Pure red cell aplasia due to persistent B19 parvovirus infection in patient infected with human immunodeficiency virus type 1: Recovery with alpha-interferon therapy. Sangre (Barc) 1998;43:67–69.

Mylonakis E , Dickinson BP , Mileno MD , . Persistent parvovirus B19 related anemia of seven years’ duration in an HIV-infected patient: Complete remission associated with highly active antiretroviral therapy. Am J Hematol 1999;60:164–166.

Anderson MJ , Higgins PG , Davis LR , . Experimental parvoviral infection in humans. J Infect Dis 1985;152:257–265.

Osborne BM , Guarda LA , Butler JJ. Bone marrow biopsies in patients with the acquired immunodeficiency syndrome. Hum Pathol 1984;15:1048–1053.

Castella A , Croxson TS , Mildvan D , Witt DH , Zalusky R. The bone marrow in AIDS: A histologic, hematologic, and microbiologic study. Am J Clin Pathol 1985;84:425–432.

Schneider DR , Picker LJ. Myelodysplasia in the acquired immune deficiency syndrome. Am J Clin Pathol 1985;84:144–152.

Zon LI , Arkin C , Groopman JE. Haematologic manifestations of the human immune deficiency virus (HIV). Br J Haematol 1987;66:251–256.

Treacy M , Lai L , Costello C , Clark A. Peripheral blood and bone marrow abnormalities in patients with HIV related disease. Br J Haematol 1987;65:289–294.

Bagnara GP , Zauli G , Giovannini M , Re MC , Furlini G , La Placa M . Early loss of circulating hemopoietic progenitors in HIV-1-infected subjects. Exp Hematol 1990;18:426–430.

Cleveland RP , Liu YC. CD4 expression by erythroid precursor cells in human bone marrow. Blood 1996;87:2275–2282.

Lee B , Ratajczak J , Doms RW , Gewirtz AM , Ratajczak MZ. Coreceptor/chemokine receptor expression on human hematopoietic cells: Biological implications for human immunodeficiency virus-type 1 infection. Blood 1999;93:1145–1156.

Chelucci C , Casella I , Federico M , . Lineage-specific expression of human immunodeficiency virus (HIV) receptor/coreceptors in differentiating hematopoietic precursors: Correlation with susceptibility to T- and M-tropic HIV and chemokine-mediated HIV resistance. Blood 1999;94:1590–1600.

Furlini G , Vignoli M , Ramazotti E , Re MC , Visani G , La Placa M. A concurrent human herpesvirus-6 infection renders two human hematopoietic progenitor (TF-1 and KG-1) cell lines susceptible to human immunodeficiency virus type-1. Blood 1996;87:4737–4745.

Molina JM , Scadden DT , Sakaguchi M , Fuller B , Woon A , Groopman JE. Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus. Blood 1990;76:2476–2481.

Steinberg HN , Crumpacker CS , Chatis PA. In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus. J Virol 1991;65:1765–1769.

Zauli G , Re MC , Giovannini M , Bagnara GP , Furlini G , Ranieri S , La Placa M . Effect of human immunodeficiency virus type 1 on CD34+ cells. Ann N Y Acad Sci 1991;628:273–279.

Zauli G , Re MC , Visani G , Furlini G , La Placa M . Inhibitory effect of HIV-1 envelope glycoproteins gp120 and gp160 on the in vitro growth of enriched (CD34+) hematopoietic progenitor cells. Arch Virol 1992;122:271–280.

Cen D , Zauli G , Szarnicki R , Davis BR. Effect of different human immunodeficiency virus type-1 (HIV-1) isolates on long-term bone marrow haemopoiesis. Br J Haematol 1993;85:596–602.

Neal TF , Holland HK , Baum CM , Villinger F , Ansari AA , Saral R , Wingard JR , Fleming WH. CD34+ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1. Blood 1995;86:1749–1756.

Kaushal S , La Russa VF , Gartner S , . Exposure of human CD34+ cells to human immunodeficiency virus type 1 does not influence the expansion and proliferation of hematopoietic progenitors in vitro. Blood 1996;88:130–137.

Koka PS , Jamieson BD , Brooks DG , Zack JA. Human immunodeficiency virus type 1-induced hematopoietic inhibition is independent of productive infection of progenitor cells in vivo. J Virol 1999;73:9089–9097.

Davis BR , Schwartz DH , Marx JC , . Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo. J Virol 1991;65:1985–1990.

Zauli G , Re MC , Visani G , . Evidence for a human immunodeficiency virus type 1-mediated suppression of uninfected hematopoietic (CD34+) cells in AIDS patients. J Infect Dis 1992;166:710–716.

Louache F , Henri A , Bettaieb A , . Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 1992;80:2991–2999.

Shen H , Cheng T , Preffer FI , . Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression. J Virol 1999;73:728–737.

Weichold FF , Zella D , Barabitskaja O , . Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most-primitive human hematopoietic stem cells as assessed in long-term bone marrow cultures. Blood 1998;91:907–915.

Esser R , Glienke W , Von Briesen H , Rubsamen-Waigmann H , Andreesen R . Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus. Blood 1996;88:3474–3481.

Scadden DT , Zeira M , Woon A , . Human immunodeficiency virus infection of human bone marrow stromal fibroblasts. Blood 1990;76:317–322.

Moses AV , Williams S , Heneveld ML , . Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood 1996;87:919–925.

Maciejewski JP , Weichold FF , Young NS. HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-alpha. J Immunol 1994;153:4303–4310.

Levine AM , Meyer PR , Begandy MK , . Development of B-cell lymphoma in homosexual men. Clinical and immunologic findings. Ann Intern Med 1984;100:7–13.

Ziegler JL , Drew WL , Miner RC , . Outbreak of Burkitt's-like lymphoma in homosexual men. Lancet 1982;2:631–633.

Sirisanthana V , Sirisanthana T. Disseminated Penicillium marneffei infection in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1995;14:935–940.

Supparatpinyo K , Khamwan C , Baosoung V , Nelson KE , Sirisanthana T .Disseminated Penicillium marneffei infection in Southeast Asia. Lancet 1994;344:110–113.

Little BJ , Spivak JL , Quinn TC , Mann RB. Kaposi's sarcoma with bone marrow involvement: Occurrence in a patient with acquired immunodeficiency syndrome. Am J Med Sci 1986;292:44–46.

Prins JM , Sol CJ , Renwick N , Goudsmit J , Veenstra J , Reiss P. Favourable effect of chemotherapy on clinical symptoms and human herpesvirus-8 DNA load in a patient with Kaposi's sarcoma presenting with fever and anemia. Eur J Clin Microbiol Infect Dis 1999;18:499–502.

Mildvan D , Mathur U , Enlow RW , . Opportunistic infections and immune deficiency in homosexual men. Ann Intern Med 1982;96:700–704.

Pasternak J , Bolivar R. Bone marrow examination and culture in the diagnosis of acquired immunodeficiency syndrome. Arch Intern Med 1983;143:1495.

Heyman MR , Rasmussen P .Pneumocystis carinii involvement of the bone marrow in acquired immunodeficiency syndrome. Am J Clin Pathol 1987;87:780–783.

Allen S , van de Perre P , Serufilira A , . Human immunodeficiency virus and malaria in a representative sample of childbearing women in Kigali, Rwanda. J Infect Dis 1991;164:67–71.

Hane AA , Thiam D , Cissokho S , . Anomalies de l'hémogramme et immundépression dans l'association VIH/sidatuberculose pulmonaire [Hemato-immunological abnormalities in tuberculosis and HIV infection in Senegal]. Bull Soc Pathol Exot 1999;92:161–163.

Bell WR , Chulay JD , Feinberg JE. Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204). Medicine 1997;76:369–380.

Viale P , Pagani L , Alberici F. Clinical features and prognostic factors of HIV-associated thrombotic microangiopathies. Eur J Haematol 1998;60:262–263.

Turner ME , Kher K , Rakusan T , . A typical hemolytic uremic syndrome in human immunodeficiency virus-1-infected children. Pediatr Nephrol 1997;11:161–163.

Peraldi MN , Maslo C , Akposso K , Mougenot B , Rondeau E , Sraer JD. Acute renal failure in the course of HIV infection: A single-institution retrospective study of ninety-two patients and sixty renal biopsies. Nephrol Dial Transplant 1999;14:1578–1585.

Gadallah MF , El-Shahawy MA , Campese VM , Todd JR , King JW. Disparate prognosis of thrombotic microangiopathy in HIV-infected patients with and without AIDS. Am J Nephrol 1996;16:466–450.

Richman DD , Fischl MA , Grieco MH , . The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1987;317:192–197.

Shaffer N , Chuachoowong R , Mock PA , . Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group Lancet 1999;353:773–780.

Wiktor SZ , Ekpini E , Karon JM , . Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: A randomised trial. Lancet 1999;353:781–785.

Dabis F , Msellati P , Meda N , . 6-month efficacy, tolerance, and acceptability of a short regiment of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: A double-blind placebo-controlled multicentre trial. DITRAME Study Group Diminution de la Transmission Mere-Enfant Lancet 1999;353:786–792.

Silverman NS , Watts DH , Hitti J , . Initial multicenter experience with double nucleoside therapy for human immunodeficiency virus infection during pregnancy. Infect Dis Obstet Gynecol 1998;6:237–243.

Tseng A , Conly J , Fletcher D , Keystone D , Salit I , Walmsley S. Precipitous declines in hemoglobin levels associated with combination zidovudine and lamivudine therapy. Clin Infect Dis 1998;27:908–909.

Hester EK , Peacock JR Jr. Profound and unanticipated anemia with lamivudine-zidovudine combination therapy in zidovudine-experienced patients with HIV infection. AIDS 1998;12:439–440.

Prazuck T , Semaille C , Roques S. Fatal acute hemolysis in an AIDS patient treated with indinavir. AIDS 1998;12:531–533.

Morrison-Griffiths S , Newman M , O'Mahony C , Pirmohamed M. Haemolytic anaemia associated with indinavir. Postgrad Med J 1999;75:313–315.

Anonymous.Antiviral briefs: Ritonavir and anemia in women. AIDS Patient Care STDS 2000;14:101–102.

Mylonakis E , Dickinson B , Feller A , . Combination antiretroviral therapy including a protease inhibitor eliminated the transfusion requirements of HIV-infected individuals with anemia of chronic disease. J Acquir Immune Defic Syndr Human Retrovirol 1998;19:306–307.